Cover Image

Microbes, microbial metabolism, and mucosal immunity : an overview /

Microbes, Microbial Metabolism and Mucosal Immunity: An Overview presents a concise and well-vetted treatise on the study of microbiome and microbial metabolites.This volume is up-to-date with the most recent developments from the last decade.

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Bose, Tanima
Format: eBook
Language:English
Published: London ; San Diego, CA : Academic Press, an imprint of Elsevier, [2024]
Subjects:
Microbial metabolism.
Immunity.
Metabolism
Immunity
Bactéries > Métabolisme.
Immunité.
Métabolisme.
metabolism (biological concept)
Electronic books.
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • 3 Role of gut microbes in shaping neonatal immunity and beyond
  • 3.1 Introduction
  • 3.2 Prenatal and postnatal establishment of microbiome
  • 3.2.1 Changes in the maternal gut microbiome during pregnancy
  • 3.2.2 Gut microbiome and pregnancy: a bi-directional relationship
  • 3.2.3 Microbial colonization and immune education in utero
  • 3.2.4 Gut microbiota and early life development
  • 3.2.5 Impact of diet and the microbiota on immune system development in early life
  • 3.2.6 Opportunities for intervention
  • 3.2.7 Role of microbial metabolites in shaping neonatal immunity
  • 3.2.8 It all starts inside: in utero microbial stimulation
  • 3.2.9 Neonatal gut microenvironment
  • 3.2.10 Microbial metabolites and associated diseases
  • 3.2.11 Role of neonatal microbiome in shaping innate immune memory
  • 3.2.12 Trained immunity in shaping the neonatal immune development
  • 3.2.13 Effect of prenatal vaccination on shaping neonatal immunity
  • 3.2.14 Immune protection through the maternal antibodies
  • 3.2.15 Maternal immune system during pregnancy
  • 3.2.16 Maternal-fetal interface
  • 3.2.17 Implications for pregnancy outcomes
  • 3.3 Prenatal vaccination and protection against specific pathogens
  • 3.3.1 Tetanus, diphtheria, and pertussis
  • 3.3.2 Influenza virus
  • 3.3.3 Maternal vaccines in development
  • 3.3.4 Respiratory syncytial virus vaccine
  • 3.3.5 Group B streptococcus vaccine
  • 3.3.6 Cytomegalovirus vaccine
  • 3.4 Streptococcus pneumoniae vaccine
  • 3.5 Group A Streptococcus vaccine
  • 3.6 Conclusions
  • Abbreviation
  • References
  • 4 Respiratory microbiome
  • 4.1 Respiratory microbiome during development and homeostasis
  • 4.2 Respiratory mycobiome and virome
  • 4.3 Microbiota dysbiosis in respiratory diseases
  • 4.4 Methods for the sampling and assessment of the respiratory microbiome.
  • 4.5 Immunomodulatory role of lung microbiome in mammalian hosts
  • 4.6 Therapeutic implications of the lung microbiome
  • 4.7 Concluding remarks
  • Abbreviations
  • References
  • 5 Oral immune system and microbes
  • 5.1 Introduction
  • 5.2 The oral microbiome
  • 5.2.1 Core oral microbiome
  • 5.2.2 Composition in different ecological niches
  • 5.2.2.1 Salivary microbiome
  • 5.2.2.2 Dental plaque microbiome
  • 5.2.2.3 Soft tissue microbiome
  • 5.2.3 Acquisition and development of oral microbiome
  • 5.3 The oral immune system
  • 5.3.1 Oral innate immunity
  • 5.3.1.1 Oral mucosal epithelial cells
  • 5.3.1.2 Oral antimicrobial peptides
  • 5.3.1.3 Oral complement system
  • 5.3.1.4 Oral mucosal innate immune cells
  • 5.3.1.5 Saliva
  • 5.3.2 Oral adaptive immunity
  • 5.3.2.1 B Lymphocytes and humoral response
  • 5.3.2.2 Lymphocytes T and cytokines
  • 5.3.3 Oral mucosa
  • 5.3.4 Gingiva, gingival sulcus and gingival crevicular fluid
  • 5.4 Factors influencing the oral microbiome and the host immunity
  • 5.4.1 Age
  • 5.4.2 Intrinsic factors
  • 5.4.3 Extrinsic factors
  • 5.5 Oral microbiome and host immunity in health
  • 5.6 Oral microbiome and host immunity dysbiosis in diseases
  • 5.6.1 Dysbiosis in periodontitis and inflammation
  • 5.6.2 Dysbiosis in caries and diet
  • 5.7 Conclusions
  • Acknowledgments
  • Abbreviations
  • References
  • 6 The eye and the microbiome
  • 6.1 Introduction
  • 6.1.1 The "healthy" gut microbiome
  • 6.1.2 The "healthy" ocular surface microbiome
  • 6.1.2.1 Human studies
  • 6.1.2.2 Animal studies
  • 6.2 Relationships between gut and ocular surface microbiome composition and eye disease
  • 6.2.1 The microbiome and Sjögren's
  • 6.2.1.1 Human studies, gut microbiome
  • 6.2.1.2 Human studies, other microbiomes
  • 6.2.1.3 Animal models
  • 6.2.1.4 Summary
  • 6.2.2 The microbiome and glaucoma
  • 6.2.2.1 Human studies, gut microbiome.
  • 6.2.2.2 Human studies, other microbiomes
  • 6.2.2.3 Animal models
  • 6.2.2.4 Summary
  • 6.2.3 The microbiome and uveitis
  • 6.2.3.1 Human studies, gut microbiome
  • 6.2.3.2 Animal models
  • 6.2.3.3 Summary
  • 6.2.4 The microbiome and age-related macular degeneration
  • 6.2.4.1 Human studies, gut microbiome
  • 6.2.4.2 Human studies, other microbiomes
  • 6.2.4.3 Animal models
  • 6.2.4.4 Summary
  • 6.2.5 The microbiome and diabetic retinopathy
  • 6.2.5.1 Human studies, gut microbiome
  • 6.2.5.2 Animal models
  • 6.2.5.3 Summary
  • 6.2.6 The microbiome and endophthalmitis
  • 6.2.6.1 Human studies, other microbiomes
  • 6.3 Conclusion
  • Financial support
  • Conflict of interest
  • Abbreviations
  • References
  • 7 Commensal virome and mycobiome
  • 7.1 Introduction
  • 7.2 Characterization of the virome and the mycobiome
  • 7.3 Specific strategies for studying the virome
  • 7.4 Specific strategies for studying the mycobiome
  • 7.5 Distribution of the virome and mycobiome in the human body
  • 7.5.1 Compartment-specific viromes
  • 7.5.2 The gastrointestinal virome
  • 7.5.3 The oral and respiratory tract virome
  • 7.5.4 The skin virome
  • 7.5.5 The genitourinary tract virome
  • 7.5.6 The blood virome
  • 7.5.7 Compartment-specific mycobiomes
  • 7.5.8 The gastrointestinal mycobiome
  • 7.5.9 The oral and respiratory mycobiome
  • 7.5.10 The skin mycobiome
  • 7.5.11 The genitourinary tract mycobiome
  • 7.6 Virome and mycobiome acquisition and development
  • 7.7 Trans-kingdom interactions
  • 7.8 Conclusions and future directions
  • Abbreviations
  • References
  • 8 Microbiome and the COVID-19 pandemic
  • 8.1 Introduction
  • 8.2 Microbiome characteristics in COVID-19
  • 8.3 Intestinal microbiome
  • 8.4 Upper respiratory tract microbiome
  • 8.5 Lower respiratory tract microbiome
  • 8.6 Oral microbiome
  • 8.7 Pediatric microbiome characteristics in COVID-19.
  • 8.8 Review of analytic methods for COVID-19 microbiome data
  • 8.8.1 Technologies
  • 8.8.2 Diversity indices
  • 8.8.3 Distance measures and visualizations
  • 8.8.4 Analytic techniques
  • 8.8.5 Discussions on analytic techniques
  • 8.9 Microbiome-based prevention and intervention approaches in COVID-19
  • 8.9.1 Probiotics
  • 8.9.2 Prebiotics
  • 8.9.3 Postbiotics
  • 8.9.4 Fecal microbiota transplantation
  • 8.10 Conclusion
  • Abbreviations
  • References
  • Author Index
  • Subject Index and Keywords
  • Back Cover.